Floatz logo

Ro-Choep-21

ALK- Anaplastic Large Cell Lymphoma (ALCL)

Fondazione Italiana Linfomi - ETSPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the ALK- Anaplastic Large Cell Lymphoma (ALCL) cohort.

Asset / SponsorPhaseRating
(+)-VINCRISTINE
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
ETOPOSIDE
City of Hope Medical Center
Phase 4BB
Ifosfamide
Shandong Provincial Hospital
Phase 4BB
PREDNISONE TABLETS
Shanghai Jiao Tong University School of Medicine
Phase 4BB
Inno-206
City of Hope Medical Center
Phase 4BB

View all 27 →

Same molecule, other indications

Ro-Choep-21 is also rated in:

mature T-cell and NK-cell non-Hodgkin lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
NR
Indicative ·
/ 100
View asset →
angioimmunoblastic T-cell lymphomaDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →